|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 25 MASSACHUSETTS AVENUE, NW |
Address2 | SUITE 600 |
City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
City | 515 N. STATE STREET, CHICAGO |
State | IL |
Zip Code | 60654 |
Country | USA |
|
5. Senate ID# 2877-12
|
||||||||
|
6. House ID# 304640000
|
TYPE OF REPORT | 8. Year | 2012 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: George E. Cox III, Division of Legislative Counsel |
Date | 04/20/2012 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 2119, Ryan Creedon Act of 2011, all provisions
H.R. 3497, MODDERN Cures Act of 2011, all provisions
H.R. 3207, Modernizing Laboratory Test Standards for Patients Act of 2011, all provisions
H.R. 866, National All Schedules Prescription Electronic Reporting (NASPER) Reauthorization Act of 2011, all provisions
H.R. 2182, Generating Antibiotic Incentives Now (GAIN) Act of 2011, all provisions
S. 1734, Generating Antibiotic Incentives Now (GAIN) Act of 2011, all provisions
H.R. 2245, Preserving Access to Life-Saving Medications Act of 2011, all provisions
S. 296, Preserving Access to Life-Saving Medications Act, all provisions
H.R. 2086, Medical Debt Responsibility Act of 2011, all provisions
S. 2149, Medical Debt Responsibility Act of 2012, all provisions
H.R. 4095, Online Pharmacy Safety Act, all provisions
S. 2002, Online Pharmacy Safety Act, all provisions
H.R. 2529, Restoring Access to Medication Act, all provisions
S. 1368, Restoring Access to Medication Act, all provisions
H.R. 2939, Pharmaceutical Stewardship Act of 2011, all provisions
S. 2096, Federal Research Public Access Act of 2012, all provisions
Patient Safety and Generic Label Improvement Act draft bill, all provisions
Affordable Care Act
Transparency Reporting/Sunshine Act Regulations
Prescription Drug User Fee Act (PDUFA)
Medical Licensing Boards and Scope of Practice
Drug Shortages
Combating prescription drug diversion
Flexible Spending Accounts
Antibiotics and drug resistant pathogens
Comparative Effectiveness Research
Physician Education - HIPAA privacy protections
Over-the-Counter Medicine
WHO data collection
International health and chronic disease
Shared Savings/Accountable Care Organizations
Health Insurance Reform
Healthcare Delivery and Payment Reform
All payer all claims databases
Definition of a Fact Box
ICD-10
Stand for Quality Coalition
Health Information Technology
Scope of Practice
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Federal Trade Commission (FTC), Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Office of Natl Drug Control Policy (NDCP), Government Accountability Office (GAO), Food & Drug Administration (FDA), Justice - Dept of (DOJ)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Margaret |
Garikes |
|
|
|
Sandy |
Marks |
|
|
|
Sharon |
McIlrath |
|
|
|
Jennifer |
Meeks |
|
|
|
Mari |
Savickis |
|
|
|
Carol |
Vargo |
|
|
|
George |
Cox |
III |
|
|
Lisa |
Assatourians |
|
|
|
Debra |
Cohn |
|
|
|
Cybil |
Roehrenbeck |
|
|
|
Kathleen |
Tenoever |
|
|
|
Sylvia |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 5, Protecting Access to Healthcare Act, Title II provisions
H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2012, provisions relating to SGR Repeal
H.R. 1700, Medicare Patient Empowerment Act, all provisions
S. 1042, Medicare Patient Empowerment Act, all provisions
H.R. 452, Medicare Decisions Accountability Act of 2011, provisions relating to IPAB Repeal
S. 668, Health Care Bureaucrats Elimination Act, all provisions
S. 2118, Health Care Bureaucrats Elimination Act, all provisions
Medicare program - Medicare Price Transparency
Medicare program - Medicare Physician Incentive and Penalty Regulations
Medicare program - MedPAC Nomination
Medicare program - Sustainable Growth Rate (SGR) Formula
Medicare program - Private Contracting
Medicare program - Overseas Contingency Operations Baseline/Funding
Medicare program - ICD-10 Repeal
Medicare program - Medicare Reform
Medicare program - IPAB Repeal
Medicare program - eRx
Medicare program - Health Information Technology
Medicare program - Physician Quality Reporting System (PQRS)
Medicare program - Group Practice Reporting Option (GPRO)
Medicare program - Observation Care
Medicare program - Codes for Molecular Pathology
Medicare program - Place of Service Reporting
Medicare program - Care Coordination Codes
Medicare program - Value-based Payment Modifier
Medicare program - Quality and Resource Use Reports
Medicare program - Conditions for hospital participation in Medicare
Medicare program - Care coordination and payment accuracy
Medicare program - Part D Drugs
Medicare program - Shared Savings/Accountable Care Organizations
Medicare program - Program Integrity
Medicare program - Meaningful Use
Medicare program - Enrollment
Medicare program - EMTALA
Medicare program - Three-day stay policy
Medicare program - Physician participation options
Medicare, Medicaid and CHIP programs - Transparency Reports/Physician Ownership Reporting
Medicare and Medicaid programs - Million Hearts Campaign
Medicare and Medicaid programs - Recovery Audit Contractors
Medicare and Medicaid programs - Quality Health Partner's Inc. CO-OP Program Application
Medicare and Medicaid programs - HIPAA (ICD-10, EFT, 5010 transaction standards)
Medicare and Medicaid programs - Delivery and payment reform
Medicare and Medicaid programs - Physician Education/HIPAA privacy protections
Medicaid program - Dual Eligibles
Medicaid program - Proposed emergency medical services policy
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Medicare Payment Advisory Commission (MedPAC), Government Accountability Office (GAO), Federal Trade Commission (FTC), Justice - Dept of (DOJ)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Margaret |
Garikes |
|
|
|
Sandy |
Marks |
|
|
|
Sharon |
McIlrath |
|
|
|
Jennifer |
Meeks |
|
|
|
Mari |
Savickis |
|
|
|
Carol |
Vargo |
|
|
|
George |
Cox |
III |
|
|
Liza |
Assatourians |
|
|
|
Debra |
Cohn |
|
|
|
Cybil |
Roehrenbeck |
|
|
|
Kathleen |
Tenoever |
|
|
|
Sylvia |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
H.R. 5, Protecting Access to Healthcare Act, Title I provisions
H.R. 3586, Good Samaritan Health Professionals Act of 2011, all provisions
H.R. 5, Protecting Access to Healthcare Act, Stearn/Matheson amendment
H.R. 816, Provider Shield Act of 2011, all provisions
S. 2002, Online Pharmacy Safety Act, provisions relating to liability
Patient Safety and Generic Label Improvement Act draft bill, provisions relating to liability
Medical Liability Reform
Physician Re-entry
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
George |
Cox |
III |
|
|
Liza |
Assatourians |
|
|
|
Cybil |
Roehrenbeck |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
S. 1979, Conrad State 30 Improvement Act, all provisions
S. 1627, Resident Physician Shortage Reduction Act of 2011, all provisions
Antitrust
DOJ-FTC Health Care Antitrust Guidelines
Health Care Market Competition
McCarran-Ferguson exemption repeal
Physician Re-entry
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, Federal Trade Commission (FTC), Justice - Dept of (DOJ), Centers For Medicare and Medicaid Services (CMS), U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Jason |
Marino |
|
|
|
Margaret |
Garikes |
|
|
|
Carol |
Vargo |
|
|
|
George |
Cox |
III |
|
|
Liza |
Assatourians |
|
|
|
Cybil |
Roehrenbeck |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Physician Charity Care and Fair Treatment of Bad Debt
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Thomas |
Roberge |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Use of credit cards for physician reimbursement
17. House(s) of Congress and Federal agencies Check if None
Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Margaret |
Garikes |
|
|
|
Mari |
Savickis |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
S. 1461, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2011, all provisions
Australia's tobacco cessation initiative
HHS Smoking Cessation Media Campaign
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. Trade Representative (USTR), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Margaret |
Garikes |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
House L-HHS FY 2012 Appropriations, provisions relating to EMTALA
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Jason |
Marino |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
5 |
|
||||||
2 |
|
6 |
|
||||||
3 |
|
7 |
|
||||||
4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
DEF |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 3 | 5 |
2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 5 | 9 |
2 | 6 | 10 |
3 | 7 | 11 |
4 | 8 | 12 |